PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) Shareholders’ equity 2011–2025
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) shareholders’ equity at each fiscal year-end, per SEC filings.
-$6.3MFY2025 · since FY2011: $10.0M → -$6.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$6.3M | -5.7% |
| FY2024 | -$6.0M | +21.5% |
| FY2023 | -$7.6M | -21.9% |
| FY2022 | -$6.2M | — |
| FY2015 | $16.3M | -35.2% |
| FY2014 | $25.2M | +280.0% |
| FY2013 | $6.6M | +50.9% |
| FY2012 | $4.4M | -56.2% |
| FY2011 | $10.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice